Granules pharmaceuticals stock
Web1 day ago · On Wednesday, the BSE Healthcare index was the top sectoral performer. It rose 2.2% to its highest level in three months to close at 22,883.08. In comparison, benchmark indices posted marginal gains to extend the rally for the eight straight sessions. The Sensex closed at 60,392.77, up 235.05 points, or 0.39%, from the previous close. WebJan 19, 2024 · We can see from the most recent balance sheet that Granules India had liabilities of ₹20.2b falling due within a year, and liabilities of ₹2.42b due beyond that. Offsetting this, it had ₹5.60b in cash and ₹8.53b in receivables that were due within 12 months. So its liabilities total ₹8.47b more than the combination of its cash and ...
Granules pharmaceuticals stock
Did you know?
WebGranules. Pharmaceuticals · India · 2,789 Employees . Granules, headquartered in Hyderabad, India, is a pharmaceutical company specializing in off-patent drugs. Their … WebGranules Pharmaceuticals Inc. (GPI) is a 100% subsidiary of Granules India located in Chantilly, Virginia. GPI is a US FDA & DEA approved facility which spreads over 100,000 sft area, with established R&D & …
WebApr 10, 2024 · Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 7,108.80 Crore) operating in Pharmaceuticals sector. … WebJul 27, 2024 · Granules Pharmaceutical Inc. (GPI), Chantilly, VA, a wholly owned subsidiary of Granules India Limited, would like to clarify that there has been no additional recall post the press release, dated July 3rd, 2024, also attached herewith. ... National Stock Exchange of India Limited BSE Limited Symbol: NSE: GRANULES; BSE: 532482 …
WebJul 27, 2024 · Granules Pharmaceutical Inc. (GPI), Chantilly, VA, a wholly owned subsidiary of Granules India Limited, would like to clarify that there has been no … WebMar 28, 2024 · granules pharmaceuticals Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. granules pharmaceuticals Blogs, Comments and Archive News on Economictimes.com ... Stock market update: Nifty Pharma index advances 0.31% in an upbeat market. The Nifty Pharma index was trading 0.31 per cent …
WebMar 21, 2024 · The packaging facility in Manassas is spread over 79,000 sq ft and has several packaging suites to service customer needs, the pharmaceutical company …
WebCheck Granules India share price, financial data and complete stock analysis.Get Granules India stock rating based on quarterly result, profit and loss account, balance sheet, shareholding pattern and annual report. ... NSE: GRANULES BSE: 532482 SECTOR: Pharmaceuticals & Drugs 102k 1k 207. 297.50-4.15 (-1.38%) NSE: Today, … high rise units abbr crosswordWebApr 10, 2024 · Market Average Movement. 5.2%. 10% most volatile stocks in IN Market. 8.6%. 10% least volatile stocks in IN Market. 3.2%. Stable Share Price: GRANULES is … how many calories in sliced cheddar cheeseWebApr 5, 2024 · The Company sells its products in the global markets, including United States of America, Canada, Latin America, Europe, Asia Pacific and India. Its wholly owned subsidiaries include Granules USA Inc, Granules Pharmaceuticals Inc, Granules Europe Limited and Granules Lifesciences Private Limited. high rise upennWebApr 11, 2024 · 532482 Stock Overview. Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. About the company high rise utility jeans targetWebCompany profile page for Granules Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information high rise units for sale cleveland qldWebGranules Pharmaceuticals, Inc., Chantilly, VA is voluntarily recalling twelve (12) lots of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, 100 and 500 count … high rise unitWebInformation on stock, financials, earnings, subsidiaries, investors, and executives for Granules India. Use the PitchBook Platform to explore the full profile. ... Granules Biocause Pharmaceuticals: 06-Mar-2007: Joint Venture: Drug Discovery: To view Granules India’s complete investments and acquisitions history, request access » high rise vanity